Literature DB >> 29781957

Quantitative sensory testing in patients with migraine: a systematic review and meta-analysis.

Hadas Nahman-Averbuch1, Tom Shefi2, Victor J Schneider1, Dan Li3, Lili Ding3, Christopher D King1, Robert C Coghill1.   

Abstract

Quantitative sensory testing (QST) is widely used to assess somatosensory function by application of controlled stimuli across a variety of modalities. The aim of the present meta-analysis is to synthesize QST results across a wide array of studies of patients with migraine to identify the QST parameters that are reliably different between patients with migraine and healthy controls. In addition, we aimed to determine whether such differences vary according to stimulus location. A comprehensive literature search (up to January 2017) was conducted, which included studies comparing QST parameters between patients with migraine and healthy controls. For each QST modality, we calculated up to 3 meta-analyses for combined (combined data from multiple testing locations), local (head and neck), and nonlocal (outside the head or neck) locations. A total of 65 studies were included in the meta-analyses. Lower heat and pressure pain thresholds were observed in patients with migraine compared with healthy controls in the combined locations. Importantly, lower pressure pain threshold in patients with migraine was found in local areas but not in nonlocal areas. In addition, patients with migraine had higher pain ratings to cold suprathreshold stimuli for combined and nonlocal areas, and higher pain ratings to electrical suprathreshold stimuli for nonlocal areas. This meta-analysis indicates that the alterations in nociceptive processing of patients with migraine may be modality, measure, and location specific. These results provide researchers and clinicians the evidence to choose QST parameters optimally suited for differentiating patients with migraine and healthy controls.

Entities:  

Mesh:

Year:  2018        PMID: 29781957     DOI: 10.1097/j.pain.0000000000001231

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  21 in total

1.  Migraine disability, pain catastrophizing, and headache severity are associated with evoked pain and targeted by mind-body therapy.

Authors:  Samuel R Krimmel; Michael L Keaser; Darrah Speis; Jennifer A Haythornthwaite; David A Seminowicz
Journal:  Pain       Date:  2022-01-17       Impact factor: 7.926

2.  Transient receptor potential melastatin 8 is required for nitroglycerin- and calcitonin gene-related peptide-induced migraine-like pain behaviors in mice.

Authors:  Chao Wei; Brian Kim; David D McKemy
Journal:  Pain       Date:  2022-03-29       Impact factor: 7.926

3.  Effects of systemic inhibitors of acid-sensing ion channels 1 (ASIC1) against acute and chronic mechanical allodynia in a rodent model of migraine.

Authors:  Clément Verkest; Emilie Piquet; Sylvie Diochot; Mélodie Dauvois; Michel Lanteri-Minet; Eric Lingueglia; Anne Baron
Journal:  Br J Pharmacol       Date:  2018-09-22       Impact factor: 8.739

4.  Cannabinoid effects on responses to quantitative sensory testing among individuals with and without clinical pain: a systematic review.

Authors:  Chung Jung Mun; Janelle E Letzen; Erica N Peters; Claudia M Campbell; Ryan Vandrey; Julia Gajewski-Nemes; Dana DiRenzo; Christine Caufield-Noll; Patrick H Finan
Journal:  Pain       Date:  2020-02       Impact factor: 7.926

5.  Upper cervical two-point discrimination thresholds in migraine patients and headache-free controls.

Authors:  Kerstin Luedtke; Waclaw Adamczyk; Katrin Mehrtens; Inken Moeller; Louisa Rosenbaum; Axel Schaefer; Janine Schroeder; Tibor Szikszay; Christian Zimmer; Bettina Wollesen
Journal:  J Headache Pain       Date:  2018-06-26       Impact factor: 7.277

6.  Sensory Processing Difficulties Correlate With Disease Severity and Quality of Life Among Children With Migraine.

Authors:  Jacob Genizi; Ayelet Halevy; Mitchell Schertz; Khaled Osman; Nurit Assaf; Idan Segal; Isaac Srugo; Aharon Kessel; Batya Engel-Yeger
Journal:  Front Neurol       Date:  2019-05-24       Impact factor: 4.003

7.  Identification of neural and psychophysical predictors of headache reduction after cognitive behavioral therapy in adolescents with migraine.

Authors:  Hadas Nahman-Averbuch; Victor J Schneider; Leigh Ann Chamberlin; Ashley M Kroon Van Diest; James L Peugh; Gregory R Lee; Rupa Radhakrishnan; Andrew D Hershey; Scott W Powers; Robert C Coghill; Christopher D King
Journal:  Pain       Date:  2021-02-01       Impact factor: 7.926

8.  Progressive vasoconstriction with sequential thermal stimulation indicates vascular dysautonomia in sickle cell disease.

Authors:  Saranya Veluswamy; Payal Shah; Maha Khaleel; Wanwara Thuptimdang; Patjanaporn Chalacheva; John Sunwoo; Christopher C Denton; Roberta Kato; Jon Detterich; John C Wood; Richard Sposto; Michael C K Khoo; Lonnie Zeltzer; Thomas D Coates
Journal:  Blood       Date:  2020-09-03       Impact factor: 25.476

9.  Sensory processing patterns affect headache severity among adolescents with migraine.

Authors:  Jacob Genizi; Ayelet Halevy; Mitchell Schertz; Khaled Osman; Nurit Assaf; Idan Segal; Isaac Srugo; Aharon Kessel; Batya Engel-Yeger
Journal:  J Headache Pain       Date:  2020-05-06       Impact factor: 7.277

10.  Individual pain sensitivity is associated with resting-state cortical activities in healthy individuals but not in patients with migraine: a magnetoencephalography study.

Authors:  Fu-Jung Hsiao; Wei-Ta Chen; Hung-Yu Liu; Yen-Feng Wang; Shih-Pin Chen; Kuan-Lin Lai; Li-Ling Hope Pan; Shuu-Jiun Wang
Journal:  J Headache Pain       Date:  2020-11-16       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.